Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites

Infection and Immunity

Volumn 73, Issue 5, 2005, Pages 2863-2872

  Wang, Ruobing ^a,b,f   Richie, Thomas L ^a   Baraceros, Maria Fe ^a,b   Rahardjo, Nancy ^a,b   Gay, Tanya ^a,b,g   Banania, Jo Glenna ^a,b   Charoenvit, Yupin ^a   Epstein, Judith E ^a   Luke, Thomas ^a,c   Freilich, Daniel A ^a   Norman, Jon ^d   Hoffman, Stephen L ^a,e  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d VICAL INC   (United States)

^e SANARIA INC   (United States)

^f J CRAIG VENTER INSTITUTE   (United States)

^g Digene Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; DNA VACCINE; EPITOPE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MULTISTAGE DNA VACCINE OPERATION 5 ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; IMMUNITY; IMMUNIZATION; MALARIA; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PLASMID; PLASMODIUM; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, PROTOZOAN; BITES AND STINGS; CULICIDAE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNIZATION; INTERFERON TYPE II; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMIDS; PLASMODIUM FALCIPARUM; T-LYMPHOCYTES; TREATMENT OUTCOME; VACCINES, DNA;

EID: 20244380773     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.5.2863-2872.2005     Document Type: Article

References (33)

1. Aidoo, M., A. Lalvani, S. C. Gilbert, J. T. Hu, P. Daubersies, N. Hurt, H. C. Whittle, P. Druihle, and A. V. Hill. 2000. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect. Immun. 68:227-232.
2. Alonso, P. L., J. Sacarlal, J. J. Aponte, A. Leach, E. Macete, J. Milman, I. Mandomando, B. Spiessens, C. Guinovart, M. Espasa, Q. Bassat, P. Aide, O. Ofori-Anyinam, M. M. Navia, S. Corachan, M. Ceuppens, M. C. Dubois, M. A. Demoitie, F. Dubovsky, C. Menendez, N. Tornieporth, W. R. Ballou, R. Thompson, and J. Cohen. 2004. Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364:1411-1420.
3. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Monteflori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H. L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
4. Daubersies, P., A. W. Thomas, P. Millet, K. Brahimi, J. A. Langermans, B. Ollomo, L. BenMohamed, B. Slierendregt, W. Eling, A. van Belkum, G. Dubreuil, J. F. Meis, C. Guerin-Marchand, S. Cayphas, J. Cohen, H. Gras-Masse, and P. Druihle. 2000. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat. Med. 6:1258-1263.
5. Doolan, D. L., and S. L. Hoffman. 2001. DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation. Int. J. Parasitol. 31:753-762.
6. Doolan, D. L., S. L. Hoffman, S. Southwood, P. A. Wentworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, A. A. Lal, D. M. Gordon, A. Oloo, and A. Sette. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7:97-112.
7. Doolan, D. L., S. Southwood, R. Chesnut, E. Appella, E. Gomez, A. Richards, Y. I. Higashimoto, A. Maewal, J. Sidney, R. A. Gramzinski, C. Mason, D. Koech, S. L. Hoffman, and A. Sette. 2000. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165:1123-1137.
8. Dranoff, G. 2002. GM-CSF-based cancer vaccines. Immunol. Rev. 188:147-154.
9. Epstein, J. E., Y. Charoenvit, K. E. Kester, R. Wang, R. Newcomer, S. Fitzpatrick, T. L. Richie, N. Tornieporth, D. G. Heppner, C. Ockenhouse, V. Majam, C. Holland, E. Abot, H. Ganeshan, M. Berzins, T. Jones, C. N. Freydberg, J. Ng, J. Norman, D. J. Carucci, J. Cohen, and S. L. Hoffman. 2004. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS, S/AS02A. Vaccine 22:1592-1603.
10. Giri, M., K. E. Ugen, and D. B. Weiner. 2004. DNA vaccines against human immunodeficiency virus type 1 in the past decade. Clin. Microbiol. Rev. 17:370-389.
11. Good, M. F. 1994. Antigenic diversity and MHC genetics in sporozoite immunity. Immunol. Lett. 41:95-98.
12. Hedstrom, R. C., D. L. Doolan, R. Wang, A. Kumar, J. B. Sacci, Jr., M. J. Gardner, J. C. Aguiar, Y. Charoenvit, M. Sedegah, J. A. Tine, M. Margalith, P. Hobart, and S. L. Hoffman. 1998. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. Int. J. Mol. Med. 2:29-38.
13. Hoffman, S. L., and E. D. Franke. 1994. Inducing protective immune responses against the sporozoite and liver stages of Plasmodium. Immunol. Lett. 41:89-94.
14. Hoffman, S. L., L. M. Goh, T. C. Luke, I. Schneider, T. P. Le, D. L. Doolan, J. Sacci, P. de la Vega, M. Dowler, C. Paul, D. M. Gordon, J. A. Stoute, L. W. Church, M. Sedegah, D. G. Heppner, W. R. Ballou, and T. L. Richie. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185:1155-1164.
15. Johnston, S. A., B. X. Qu, M. McGuire, K. Stemke-Hale, and K. Sykes. 2000. Applications of, and future challenges for, genetic vaccines. Dev. Biol. (Basel) 104:3-8.
16. Kumar, S., J. E. Epstein, T. L. Richie, F. K. Nkrumah, L. Soisson, D. J. Carucci, and S. L. Hoffman. 2002. A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol. 18:129-135.
17. Lau, R., F. Wang, G. Jeffery, V. Marty, J. Kuniyoshi, E. Bade, M. E. Ryback, and J. Weber. 2001. Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma. J. Immunother. 24:66-78.
18. McConkey, S. J., W. H. Reece, V. S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J. M. Vuola, T. J. Blanchard, P. Gothard, K. Watkins, C. M. Hannan, S. Everaere, K. Brown, K. E. Kester, J. Cummings, J. Williams, D. G. Heppner, A. Pathan, K. Flanagan, N. Arulanantham, M. T. Roberts, M. Roy, G. L. Smith, J. Schneider, T. Peto, R. E. Sinden, S. C. Gilbert, and A. V. Hill. 2003. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9:729-735.
19. Meraldi, V., I. Nebie, R. Moret, N. Cuzin-Ouattara, A. Thiocone, O. Doumbo, F. Esposito, A. S. Traore, G. Corradin, and S. Terenzi. 2002. Recognition of synthetic polypeptides corresponding to the N- and C-terminal fragments of Plasmodium falciparum Exp-1 by T-cells and plasma from human donors from African endemic areas. Parasite Immunol. 24:141-150.
20. Parker, S. E., D. Monteith, H. Horton, R. Hof, P. Hernandez, A. Vilalta, J. Hartikka, P. Hobart, C. E. Bentley, A. Chang, R. Hedstrom, W. O. Rogers, S. Kumar, S. L. Hoffman, and J. A. Norman. 2001. Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther. 8:1011-1023.
21. Richie, T. L., and A. Saul. 2002. Progress and challenges for malaria vaccines. Nature 415:694-701.
22. Robinson, H. L., D. C. Montefiori, R. P. Johnson, K. H. Manson, M. L. Kalish, J. D. Lifson, T. A. Rizvi, S. Lu, S. L. Hu, G. P. Mazzara, D. L. Panicali, J. G. Herndon, R. Glickman, M. A. Candido, S. L. Lydy, M. S. Wyand, and H. M. McClure. 1999. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat. Med. 5:526-534.
23. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
24. Sedegah, M., W. Weiss, J. B. Sacci, Jr., Y. Charoenvit, R. Hedstrom, K. Gowda, V. F. Majam, J. Tine, S. Kumar, P. Hobart, and S. L. Hoffman. 2000. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus. J. Immunol. 164:5905-5912.
25. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
26. + T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 72:5648-5653.
27. Wang, R., D. L. Doolan, Y. Charoenvit, R. C. Hedstrom, M. J. Gardner, P. Hobart, J. Tine, M. Sedegah, V. Fallarme, J. B. Sacci, Jr., M. Kaur, D. M. Klinman, S. L. Hoffman, and W. R. Weiss. 1998. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect. Immun. 66:4193-4202.
28. Wang, R., D. L. Doolan, T. P. Le, R. C. Hedstrom, K. M. Coonan, Y. Charoenvit, T. R. Jones, P. Hobart, M. Margalith, J. Ng, W. R. Weiss, M. Sedegah, C. de Taisne, J. A. Norman, and S. L. Hoffman. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282:476-480.
29. + type 1 responses in humans by a malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 98:10817-10822.
30. + T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. J. Immunol. 172:5561-5569.
31. Weber, J., V. K. Sondak, R. Scotland, R. Phillip, F. Wang, V. Rubio, T. B. Stuge, S. G. Groshen, C. Gee, G. G. Jeffery, S. Sian, and P. P. Lee. 2003. Granulocyte-macrophage colony-stimulating factor added to a multipeptide vaccine for resected stage II melanoma. Cancer 97:186-200.
32. Weiner, D. B., and R. C. Kennedy. 1999. Genetic vaccines. Sci. Am. 281:50-57.
33. Weiss, W. R., K. J. Ishii, R. C. Hedstrom, M. Sedegah, M. Ichino, K. Barnhart, D. M. Klinman, and S. L. Hoffman. 1998. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J. Immunol. 161:2325-2332.